1Miller AB,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207.
2Kim YH,Chows S,Varghese A,et al.Clinical characteristic and long-term outcome of patients with generalized patch and/or plaque(T2)mycosis fungoides[J].Arch Dermatol,1999,135(1):26.
3Fierro MT,Quaglino P,Savoia P,et al.Systemic polychemotherapy in the treatment of primary cutaneous lymphomas:a clinical follow-up study of 81patients treated with COP or CHOP[J].Leuk Lymphoma,1998,31(56):583.
4Foss FM . Activity of pentostatin(Nipent) in cautaneous T-cell lymphoma:single-agent and combination studies[J].Semin Oncol,2000,27(2 suppl 5):58.
5Jumbou O,Nguyen JM,Tessier MH,et al.Long-term follow-up in 51 patients with mycosis fungoides and Sezary syndrome treated by interferon-alfa[J].Br J Dermato,1999,140(3):427.
6Legha SS . Durable complete responses in metastatic melanoma treated with interleukin-2 and chemotherapy[J].Semin Oncol,1997,24(suppl 4):39.
7Hakansson A,Hakansson L,Gustafsson B,et al.On the effect of biochemotherapy in metastatic malignant melanoma:an immunopathological evaluation[J].Melanoma Res,2003,13(4):401.
8Mattes J,Hulett M,Xie W,et al.Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells:an eotaxin and STAT6-dependent process[J].J Exp Med,2003,197(3):387.
同被引文献16
1[2]Willemze R,Jaffe ES,Burg G,et al.WHO-EORTC classification fox cutaneous lymphomas[J].Blood,2005,105(10):3768-3785.
2[3]Van Vloyen WA,Willemze R.New technique in the evaluation of cutaneous T-cell lymphomas[J].Dermatol Clin,1985,3:665-672.
3[4]Surarez-Varelam M,Gonzalez AL,Vila AM,et al.Mycosis fungoides:review of epidemiological observations[J].Dermatol,2000,201(1):21-28.
4[6]Van Door NR,Van Haselen CW,Van Voorst Vader PC,et al.Mycosis fungoides:disease evolution and prognosis of 309 Dutch patients[J].Arch Dermatol,2000,136(4):504-510.
5[12]Orenstein A,Haik J,Tamir J,et al.Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application[J].Dermatol Surg,2000,26(8):765-769.
6[13]Bisaccia E,Gonzalez J,Palangio M,et al.Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma:9-year retrospective study at a single institution[J].J Am Acad Dermatol,2000,43(2 pt 1)263-271.
7[14]Kim YH,Chow S,Varghese A,et al.Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides[J].Arch Dermatol,1999,135(1):26-32.
8[15]Fierro MT,Quaglino P,Savoia P,et al.Systemic polychemotherapy in the treatment of primary cutaneous lymphomas:a clinical follow-up study of 81 patients treated with COP or CHOP[J].Leuk Lymphoma,1998,31 (5-6):583-588.
9[17]Jose GW,Rosenthal D,Wilson LD.Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)[J].Cancer,1999,85 (9):1985-1995.
10[18]Diamandidou E,Colome M,Fayad L,et al.Prognostic factor analysis in mycosis fungoides/Sezary syndrome[J].J Am Acad Dermatol,1999,40(6 Pt 1):914-924.
